CAMBRIDGE, Mass., April 15, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive results from the 4-week multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as… Read More..

SANTA BARBARA, Calif., April 14, 2025 – PRISM MediaWire – DRYWORLD Brands Inc. (OTC: IBGR) (the ‘Company’), a leading sportswear and performance brand, today announceda strategic partnership with Salsa Futsal, a dynamic futsal club, to provide official Ronaldinho brand uniforms, training gear, and fan merchandise as part of their USA… Read More..

ASHBURN, Va., April 10, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases, today announced the release of the second episode in its “Living with… Read More..